NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, April 10, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) ...

Detailed price information for Zentalis Pharmaceuticals Inc (ZNTL-Q) from The Globe and Mail including charting and trades.

For Martin, who lives full-time near the beach in Southampton, N.Y., that means prioritizing a healthy, balanced lifestyle.

US and China-based ProfoundBio will use part of the proceeds for a pivotal trial in ovarian cancer of rinatabart ... Surveyor Capital, Medicxi, Logos Capital, Octagon Capital, Piper Heartland ...

Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine ...

Ovarian cancer, a leading cause of death among gynecological malignancies, has a poor prognosis and low 5-year survival rate, necessitating new therapeutic strategies. CDK4/6 inhibitors show ...

Her doctor was concerned, but mentioned that the bleeding could be due to an internal hemorrhoid, which is common after childbirth. But results from an at-home stool test indicated Qadir needed a ...

To optimize treatment outcomes for patients whose late-stage cancer shows resistance to the standard treatment, Sarasota Memorial Research Institute will participate in testing an experimental ...

A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...

This particular genetic mutation is most commonly associated with an increased risk for breast cancer and ovarian cancer, says Parikh, who is also Qadir’s oncologist. While we can screen for ...